Contact
Privacy
DMCA
Robuta
https://stanfordhealthcare.org/publications/903/903415.html
903415 | Stanford Health Care
Second-Line Chimeric Antigen Receptor T Cell Therapy (CAR-T) As Standard of Care for Relapsed-Refractory Large B-Cell Lymphoma (LBCL)
stanford
health
care